- The study aims to explore how the preoperative systemic immune-inflammation index (SII) affects relapse-free survival (RFS) in patients with mucoepidermoid carcinoma (MEC) following surgery.
- Analysis of data from 135 MEC patients revealed that those with a lower SII had significantly better survival rates, and factors like high SII, low tumor differentiation, and cervical lymph node metastasis were linked to poor RFS.
- A nomogram model was developed based on these findings to effectively predict RFS, confirming that lower preoperative SII correlates with better patient outcomes.